Skip to main content

Peer Review reports

From: Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma

Original Submission
27 Jul 2016 Submitted Original manuscript
12 Dec 2016 Reviewed Reviewer Report - Ryan Sullivan
12 Dec 2016 Reviewed Reviewer Report - Rodabe Amaria
29 Dec 2016 Reviewed Reviewer Report - Bonnie Elyssa Gould Rothberg
9 Jan 2017 Reviewed Reviewer Report - Ian Watson
12 Apr 2017 Author responded Author comments - Johan Falkenius
Resubmission - Version 2
12 Apr 2017 Submitted Manuscript version 2
6 Jul 2017 Reviewed Reviewer Report - Ryan Sullivan
6 Jul 2017 Reviewed Reviewer Report - Bonnie Elyssa Gould Rothberg
10 Jul 2017 Reviewed Reviewer Report - Ian Watson
9 Aug 2017 Author responded Author comments - Johan Falkenius
Resubmission - Version 3
9 Aug 2017 Submitted Manuscript version 3
18 Aug 2017 Author responded Author comments - Johan Falkenius
Resubmission - Version 4
18 Aug 2017 Submitted Manuscript version 4
Publishing
22 Aug 2017 Editorially accepted
29 Aug 2017 Article published 10.1186/s12885-017-3577-x

You can find further information about peer review here.

Back to article page